LDLR and atherosclerosis: Treatment of atherosclerosis-prone LDL receptor gene knockout (Ldlr KO) or apolipoprotein E (ApoE) KO mice with agonists reported to be selective for S1PR1 have been shown in some studies, but not others, to protect against atherosclerosis development [24,25,26].